Makers of monoclonal antibody treatments say they have shown the therapies can help prevent severe coronavirus disease in people who are already infected. Now they're planning to ask the US Food and Drug Administration for authorization to use them as a kind of "passive vaccine" to protect people at high risk of infection.
January 28, 2021 at 05:49AM https://ift.tt/2Yn34ek of monoclonal antibody treatments say they have shown the therapies can help prevent severe coronavirus disease in people who are already infected. Now they're planning to ask the US Food and Drug Administration for authorization to use them as a kind of "passive vaccine" to protect people at high risk of infection.
0 comments:
Post a Comment